» Articles » PMID: 24782851

Counteraction of the Multifunctional Restriction Factor Tetherin

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2014 May 1
PMID 24782851
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The interferon-inducible restriction factor tetherin (also known as CD317, BST-2 or HM1.24) has emerged as a key component of the antiviral immune response. Initially, tetherin was shown to restrict replication of various enveloped viruses by inhibiting the release of budding virions from infected cells. More recently, it has become clear that tetherin also acts as a pattern recognition receptor inducing NF-κB-dependent proinflammatory gene expression in virus infected cells. Whereas the ability to restrict virion release is highly conserved among mammalian tetherin orthologs and thus probably an ancient function of this protein, innate sensing seems to be an evolutionarily recent activity. The potent and broad antiviral activity of tetherin is reflected by the fact that many viruses evolved means to counteract this restriction factor. A continuous arms race with viruses has apparently driven the evolution of different isoforms of tetherin with different functional properties. Interestingly, tetherin has also been implicated in cellular processes that are unrelated to immunity, such as the organization of the apical actin network and membrane microdomains or stabilization of the Golgi apparatus. In this review, I summarize our current knowledge of the different functions of tetherin and describe the molecular strategies that viruses have evolved to antagonize or evade this multifunctional host restriction factor.

Citing Articles

The Deubiquitinase OTUD1 Influences HIV-1 Release by Regulating the Host Restriction Factor BST-2.

Zhang M, Chen F, He W, Lu Y, Liu F, Zhang H Viruses. 2025; 17(2).

PMID: 40007014 PMC: 11860778. DOI: 10.3390/v17020260.


Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin.

Shi Y, Simpson S, Chen Y, Aull H, Benjamin J, Serra-Moreno R PLoS Pathog. 2024; 20(1):e1011912.

PMID: 38190411 PMC: 10798645. DOI: 10.1371/journal.ppat.1011912.


Host cell restriction factors of equine infectious anemia virus.

Wang X, Zhang X, Ma W, Li J, Wang X Virol Sin. 2023; 38(4):485-496.

PMID: 37419416 PMC: 10436108. DOI: 10.1016/j.virs.2023.07.001.


hnRNP K Degrades Viral Nucleocapsid Protein and Induces Type I IFN Production to Inhibit Porcine Epidemic Diarrhea Virus Replication.

Qin W, Kong N, Wang C, Dong S, Zhai H, Zhai X J Virol. 2022; 96(22):e0155522.

PMID: 36317879 PMC: 9682996. DOI: 10.1128/jvi.01555-22.


Bone marrow stromal cell antigen 2(BST2) suppresses the migration and invasion of trophoblasts in preeclampsia by downregulating matrix metallopeptidase 2(MMP2).

Jinyu L, Shuying W, Panchan Z, Dan C, Chao C, Xingyu Y Bioengineered. 2022; 13(5):13174-13187.

PMID: 35635087 PMC: 9276030. DOI: 10.1080/21655979.2022.2074712.


References
1.
Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin A . Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog. 2010; 6(6):e1000955. PMC: 2887479. DOI: 10.1371/journal.ppat.1000955. View

2.
Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W . Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC Cancer. 2009; 9:102. PMC: 2674058. DOI: 10.1186/1471-2407-9-102. View

3.
Swiecki M, Scheaffer S, Allaire M, Fremont D, Colonna M, Brett T . Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem. 2010; 286(4):2987-97. PMC: 3024793. DOI: 10.1074/jbc.M110.190538. View

4.
Yondola M, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C . Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol. 2011; 85(6):2480-91. PMC: 3067929. DOI: 10.1128/JVI.02188-10. View

5.
Wang S, Huang K, Wang C . BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface. Virology. 2014; 449:287-96. PMC: 7111910. DOI: 10.1016/j.virol.2013.11.030. View